Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18812691 | Parallel Bitwise Determination of Origin | August 2024 | June 2025 | Abandon | 10 | 1 | 0 | No | No |
| 18198558 | Ancestry Finder | August 2023 | December 2024 | Abandon | 19 | 1 | 0 | No | No |
| 17542398 | HIERARCHICAL MACHINE LEARNING TECHNIQUES FOR IDENTIFYING MOLECULAR CATEGORIES FROM EXPRESSION DATA | December 2021 | November 2024 | Allow | 36 | 5 | 1 | Yes | No |
| 17499068 | PREDICTION OF INFECTION IN PLANT PRODUCTS | October 2021 | March 2025 | Allow | 41 | 2 | 0 | Yes | No |
| 17449081 | GENETIC COMPARISONS BETWEEN GRANDPARENTS AND GRANDCHILDREN | September 2021 | February 2025 | Allow | 41 | 1 | 0 | No | No |
| 17396279 | DATABASE AND DATA PROCESSING SYSTEM FOR USE WITH A NETWORK-BASED PERSONAL GENETICS SERVICES PLATFORM | August 2021 | May 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17339153 | METHOD AND SYSTEM FOR THE SAFETY, ANALYSIS AND SUPERVISION OF INSULIN PUMP ACTION AND OTHER MODES OF INSULIN DELIVERY IN DIABETES | June 2021 | November 2024 | Allow | 42 | 2 | 0 | Yes | No |
| 17289930 | METHOD FOR ESTIMATING SURVIVAL OF COLCHICINE-INTOXICATED PATIENTS | April 2021 | December 2024 | Abandon | 44 | 0 | 1 | No | No |
| 17279565 | MICROBIOTA COMPOSITION, AS A MARKER OF RESPONSIVENESS TO ANTI-PD1/PD-L1/PD-L2 | March 2021 | March 2025 | Abandon | 48 | 0 | 1 | No | No |
| 17277446 | PHENOTYPIC AND MOLECULAR CHARACTERISATION OF SINGLE CELLS | March 2021 | March 2025 | Abandon | 48 | 0 | 1 | No | No |
| 17190915 | COMPUTATIONAL TECHNIQUES FOR IDENTIFYING THE SURFACE OF A BRAIN | March 2021 | February 2025 | Abandon | 47 | 1 | 0 | No | No |
| 17255485 | AUTOMATED SYSTEM FOR CONTROLLING THE BLOOD SUGAR OF A PATIENT | December 2020 | April 2025 | Allow | 52 | 2 | 0 | Yes | No |
| 17126039 | METHODS OF EFFICIENTLY TRANSFORMING AND COMPARING RECOMBINABLE DNA INFORMATION | December 2020 | April 2025 | Allow | 52 | 7 | 0 | Yes | No |
| 17047325 | CLINICAL INTERPRETATION OF GENOMIC AND TRANSCRIPTOMIC DATA AT THE POINT OF CARE FOR PRECISION CANCER MEDICINE | October 2020 | December 2024 | Abandon | 50 | 2 | 0 | Yes | No |
| 16947678 | IDENTIFYING VARIANTS OF INTEREST BY IMPUTATION | August 2020 | December 2024 | Abandon | 52 | 2 | 0 | Yes | No |
| 16874470 | BAMBAM: PARALLEL COMPARATIVE ANALYSIS OF HIGH-THROUGHPUT SEQUENCING DATA | May 2020 | March 2025 | Allow | 58 | 3 | 0 | Yes | No |
| 16862266 | HAPLOTYPE PHASING MODELS | April 2020 | May 2025 | Allow | 60 | 3 | 0 | Yes | No |
| 16854754 | SYSTEMS AND METHODS FOR VISUALIZING STRUCTURAL VARIATION AND PHASING INFORMATION | April 2020 | April 2025 | Allow | 60 | 3 | 0 | Yes | No |
| 16853712 | CREATION OR USE OF ANCHOR-BASED DATA STRUCTURES FOR SAMPLE-DERIVED CHARACTERISTIC DETERMINATION | April 2020 | June 2025 | Abandon | 60 | 2 | 0 | Yes | Yes |
| 16631778 | Systems and Methods for Analyzing Mixed Cell Populations | January 2020 | December 2024 | Allow | 59 | 4 | 1 | No | No |
| 16701162 | ANCESTRAL HUMAN GENOMES | December 2019 | July 2024 | Allow | 56 | 2 | 0 | Yes | No |
| 16669261 | ANALYSIS OF DATA OBTAINED FROM MICROARRAYS | October 2019 | April 2025 | Abandon | 60 | 3 | 0 | No | No |
| 16597302 | METHOD AND SYSTEM FOR INTERACTION ANALYSIS | October 2019 | March 2025 | Allow | 60 | 4 | 0 | Yes | No |
| 16562186 | SYSTEMS, METHODS, AND COMPOSITIONS FOR VIRAL-ASSOCIATED TUMORS | September 2019 | March 2025 | Allow | 60 | 5 | 0 | Yes | No |
| 16387049 | COMBINED SIZE- AND COUNT-BASED ANALYSIS OF MATERNAL PLASMA FOR DETECTION OF FETAL SUBCHROMOSOMAL ABERRATIONS | April 2019 | August 2024 | Allow | 60 | 3 | 0 | Yes | No |
| 15777091 | METHODS FOR DETECTING COPY-NUMBER VARIATIONS IN NEXT-GENERATION SEQUENCING | May 2018 | November 2024 | Abandon | 60 | 6 | 1 | Yes | No |
| 15967501 | SYSTEMS AND METHODS FOR THE ANALYSIS OF PROXIMITY BINDING ASSAY DATA | April 2018 | January 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 15964180 | INTERACTIVE PRECISION MEDICINE EXPLORER FOR GENOMIC ABBERATIONS AND TREATMENT OPTIONS | April 2018 | March 2025 | Abandon | 60 | 8 | 0 | Yes | No |
| 13969935 | METHOD AND APPARATUS FOR PERFORMING SIMILARITY SEARCHING | August 2013 | September 2016 | Allow | 37 | 1 | 1 | No | No |
| 13787137 | PREDICTING RISK OF MAJOR ADVERSE CARDIAC EVENTS | March 2013 | September 2017 | Allow | 54 | 4 | 0 | Yes | Yes |
| 13645086 | DRUG SUBSTANCE INTERACTION AND GENERIC SUBSTANCE INFORMATION RETRIEVAL | October 2012 | August 2017 | Allow | 58 | 4 | 1 | No | No |
| 13475183 | MINIMIZATION OF SURPRISAL DATA THROUGH APPLICATION OF HIERARCHY OF REFERENCE GENOMES | May 2012 | May 2014 | Allow | 24 | 1 | 1 | No | No |
| 12947063 | LEAST-SQUARE DECONVOLUTION (LSD): A METHOD TO RESOLVE DNA MIXTURES | November 2010 | November 2011 | Allow | 12 | 1 | 0 | Yes | No |
| 12942770 | METHOD OF CLASSIFYING GENE EXPRESSION STRENGTH IN LUNG CANCER TISSUES | November 2010 | April 2012 | Allow | 17 | 1 | 1 | No | No |
| 12844668 | PAIRING PROCESSES FOR PREPARING ALLOREACTIVE CYTOTOXIC T CELLS | July 2010 | April 2013 | Allow | 33 | 1 | 2 | No | No |
| 12309162 | DIAGNOSTIC METHOD | November 2009 | June 2012 | Allow | 41 | 1 | 1 | No | No |
| 12609578 | IDENTIFICATION, MONITORING AND TREATMENT OF DISEASE AND CHARACTERIZATION OF BIOLOGICAL CONDITION USING GENE EXPRESSION PROFILES | October 2009 | June 2011 | Allow | 20 | 1 | 1 | No | No |
| 12541146 | PHARMACO-GENOMIC MUTATION LABELING | August 2009 | August 2013 | Allow | 48 | 3 | 1 | No | No |
| 12486545 | METHOD TO IDENTIFY CANCER FUSION GENES | June 2009 | August 2012 | Allow | 38 | 2 | 0 | Yes | No |
| 12437329 | SELECTION OF SIGNAL REGIONS FOR PARAMETER EXTRACTION | May 2009 | March 2013 | Allow | 46 | 2 | 1 | Yes | No |
| 12437326 | Consistent Signal Selection By Signal Segment Selection Techniques | May 2009 | May 2013 | Allow | 48 | 2 | 1 | Yes | No |
| 12379520 | BIOMARKERS FOR AGING | February 2009 | March 2010 | Allow | 13 | 1 | 0 | No | No |
| 12083153 | Method for Analyzing Gene Expression Data | February 2009 | December 2012 | Allow | 56 | 2 | 1 | No | No |
| 12271944 | METHOD TO DETERMINE TRANSCRIPTIONAL REGULATION PATHWAYS IN ORGANISMS | November 2008 | June 2012 | Allow | 43 | 2 | 1 | No | No |
| 12208900 | TECHNIQUES FOR RECORDING SIGNALS | September 2008 | June 2012 | Allow | 45 | 4 | 0 | No | Yes |
| 12092952 | METHODS FOR THE IDENTIFICATION OF MICRORNA AND THEIR APPLICATIONS IN RESEARCH AND HUMAN HEALTH | September 2008 | September 2011 | Allow | 41 | 1 | 1 | No | No |
| 12205889 | CALCULATING SAMPLE SIZE FOR CLINICAL TRIAL | September 2008 | June 2013 | Allow | 58 | 3 | 0 | Yes | No |
| 12049949 | METHODS FOR RAPID FORENSIC ANALYSIS OF MITOCHONDRIAL DNA | March 2008 | March 2012 | Allow | 48 | 2 | 1 | No | No |
| 12074200 | PROTEIN SYNTHESIS MODULATORS | February 2008 | November 2012 | Allow | 57 | 2 | 1 | Yes | No |
| 12072980 | PROTEIN SYNTHESIS MODULATORS | February 2008 | September 2012 | Allow | 54 | 3 | 0 | No | No |
| 11956570 | APPARATUS AND METHOD FOR CODING GENETIC INFORMATION | December 2007 | May 2009 | Allow | 17 | 1 | 0 | No | No |
| 11846406 | PHARMACOGENETIC METHOD FOR PREDICTION OF THE EFFICACY OF METHOTREXATE MONOTHERAPY IN RECENT-ONSET ARTHRITIS | August 2007 | September 2011 | Allow | 49 | 2 | 1 | No | No |
| 11841660 | METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME | August 2007 | January 2013 | Allow | 60 | 3 | 1 | No | No |
| 10592309 | SYSTEM AND METHOD FOR CLASSIFYING A BODY TISSUE SAMPLE | July 2007 | October 2011 | Allow | 60 | 2 | 1 | No | No |
| 11697665 | SYSTEMS AND METHODS FOR PREDICTING AN INDIVIDUAL'S RISK OF DEVELOPING RHEUMATOID ARTHRITIS | April 2007 | January 2010 | Allow | 33 | 1 | 0 | No | No |
| 11732442 | PROGNOSTIC AND DIAGNOSTIC METHOD FOR CANCER THERAPY | April 2007 | September 2010 | Allow | 42 | 1 | 1 | Yes | No |
| 11705055 | GENOTYPING RESULT EVALUATION METHOD AND SYSTEM | February 2007 | May 2010 | Allow | 39 | 2 | 0 | No | No |
| 11617042 | MICRORNA PRECURSORS | December 2006 | June 2011 | Allow | 54 | 1 | 1 | Yes | No |
| 11617038 | MICRORNA MOTIFS | December 2006 | December 2010 | Allow | 48 | 1 | 0 | No | No |
| 11610185 | METHOD AND APPARATUS FOR DETERMINING SPECIFICITY OF A CANDIDATE PROBE | December 2006 | August 2010 | Allow | 44 | 2 | 0 | Yes | No |
| 11506089 | METHOD FOR THE DESIGN OF OLIGONUCLEOTIDES FOR MOLECULAR BIOLOGY TECHNIQUES | August 2006 | August 2010 | Allow | 48 | 1 | 1 | No | No |
| 11493838 | METHOD AND SYSTEM FOR ROBUST CLASSIFICATION STRATEGY FOR CANCER DETECTION FROM MASS SPECTROMETRY DATA | July 2006 | October 2010 | Allow | 51 | 2 | 0 | No | No |
| 11413183 | LEAST-SQUARE DECONVOLUTION (LSD): A METHOD TO RESOLVE DNA MIXTURES | April 2006 | October 2009 | Allow | 42 | 1 | 1 | No | No |
| 11008265 | METHOD OF CLASSIFYING GENE EXPRESSION STRENGTH IN LUNG CANCER TISSUES | December 2004 | August 2010 | Allow | 60 | 4 | 1 | No | No |
| 10494543 | METHODS AND APPARATUS FOR PROTEIN SEQUENCE AYALYSIS | October 2004 | September 2010 | Allow | 60 | 5 | 2 | Yes | No |
| 10711806 | TOXICITY REPORTING SYSTEM | October 2004 | July 2012 | Allow | 60 | 6 | 0 | No | No |
| 10938394 | METHOD OF MODELING FOR DRUG DESIGN, EVALUATION, AND PRESCRIPTION IN THE TREATMENT OF DISEASE | September 2004 | May 2011 | Allow | 60 | 4 | 1 | Yes | No |
| 10474385 | SYSTEM FOR CELLULAR STORAGE AND GENETIC INFORMATION RETRIEVAL | May 2004 | November 2007 | Allow | 50 | 5 | 0 | No | Yes |
| 10786321 | SAFETY TEST SUPPORT SYSTEM, METHOD AND PROGRAM | February 2004 | November 2007 | Allow | 45 | 1 | 0 | No | No |
| 10714791 | COMPUTER SYSTEM AND METHOD FOR CALCULATING A PHARMACOKINETIC BEHAVIOR OF A CHEMICAL SUBSTANCE IN INSECTS | November 2003 | January 2009 | Allow | 60 | 2 | 1 | Yes | No |
| 10639608 | TECHNIQUE FOR ANALYZING ARRAYED SIGNALS USING QUANTUM EXPRESSOR FUNCTIONS | August 2003 | May 2005 | Allow | 21 | 2 | 0 | No | No |
| 10633611 | CHEMICAL ARRAY WITH TEST DEPENDENT SIGNAL READING OR PROCESSING | July 2003 | October 2007 | Allow | 51 | 4 | 1 | Yes | No |
| 10453194 | FORENSIC AND GENEALOGICAL TEST | June 2003 | March 2007 | Allow | 45 | 4 | 0 | Yes | No |
| 10329056 | METHODS AND COMPOSITIONS FOR REGULATING BONE AND CARTILAGE FORMATION | December 2002 | March 2007 | Allow | 50 | 2 | 2 | No | No |
| 10317034 | METHOD FOR CREATING SPECIFIC, HIGH AFFINITY NUCLEAR RECEPTOR PHARMACEUTICALS | December 2002 | June 2007 | Allow | 54 | 3 | 1 | Yes | Yes |
| 10262124 | BIOPOLYMER ARRAY SCANNER WITH REAL-TIME SATURATION DETECTION | September 2002 | October 2005 | Allow | 36 | 2 | 1 | No | No |
| 10172485 | NUCLEAR MAGNETIC RESONANCE ASSEMBLY OF CHEMICAL ENTITIES | June 2002 | September 2009 | Allow | 60 | 4 | 1 | No | Yes |
| 10146720 | METHOD AND SYSTEM FOR IDENTIFYING SPLICE VARIANTS OF A GENE | May 2002 | October 2007 | Allow | 60 | 4 | 1 | No | No |
| 10141099 | PROBE DESIGNING APPARATUS AND PROBE DESIGNING METHOD | May 2002 | November 2005 | Allow | 42 | 3 | 1 | Yes | No |
| 10113219 | METHOD AND SYSTEM TO BUILD OPTIMAL MODELS OF 3-DIMENSIONAL MOLECULAR STRUCTURES | March 2002 | March 2005 | Abandon | 36 | 2 | 0 | Yes | No |
| 10100262 | CLUSTER ANALYSIS OF GENETIC MICROARRAY IMAGES | March 2002 | November 2005 | Allow | 43 | 2 | 1 | No | No |
| 10081904 | METHODS FOR ESTABLISHING A PATHWAYS DATABASE AND PERFORMING PATHWAY SEARCHES | February 2002 | June 2005 | Allow | 40 | 1 | 1 | Yes | No |
| 10058216 | METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR ANALYZING COMBINATORIAL LIBRARIES | January 2002 | November 2005 | Allow | 46 | 3 | 1 | No | No |
| 09977064 | INTERACTIVE CORRELATION OF COMPOUND INFORMATION AND GENOMIC INFORMATION | October 2001 | December 2005 | Allow | 50 | 3 | 1 | Yes | No |
| 09970966 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER | October 2001 | November 2003 | Allow | 25 | 2 | 1 | No | No |
| 09961058 | AUTOMATED METHOD OF IDENTIFYING AND ARCHIVING NUCLEIC ACID SEQUENCES | September 2001 | October 2004 | Allow | 37 | 2 | 0 | No | No |
| 09949015 | METHODS FOR CELL-BASED COMBINATORIAL LOGIC | September 2001 | December 2005 | Allow | 51 | 4 | 1 | Yes | No |
| 09924400 | COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF BREAST CANCER | August 2001 | January 2007 | Allow | 60 | 6 | 1 | Yes | Yes |
| 09875935 | METHOD FOR GENE MAPPING FROM CHROMOSOME AND PHENOTYPE DATA | June 2001 | February 2005 | Allow | 44 | 2 | 0 | No | Yes |
| 09866543 | A VIRTUAL LIBRARY SEARCHABLE FOR POSSIBLE COMBINATORIALLY DERIVED PRODUCT MOLECULES HAVING DESIRED PROPERTIES WITHOUT THE NECESSITY OF GENERATING PRODUCT STRUCTURES | May 2001 | June 2006 | Allow | 60 | 4 | 1 | Yes | Yes |
| 09830558 | SYSTEM FOR REGULATING THE HANDLING OF MILK DURING THE MILKING PROCESS AND A METHOD FOR REGULATING SAID MILKING PROCESS | May 2001 | December 2004 | Allow | 43 | 3 | 0 | No | No |
| 09846328 | BIOPOLYMER MARKER INDICATIVE OF DISEASE STATE HAVING A MOLECULAR WEIGHT OF 2753 DALTONS | April 2001 | June 2005 | Abandon | 50 | 3 | 1 | No | No |
| 09744291 | METHOD FOR ANALYSIS OF BIOLOGICAL SYSTEMS | April 2001 | May 2005 | Allow | 52 | 2 | 1 | Yes | Yes |
| 09804866 | SEQUENCING OF PEPTIDES BY MASS SPECTROMETRY | March 2001 | October 2003 | Allow | 31 | 1 | 0 | No | No |
| 09776711 | COMPUTER-IMPLETMENTED METHOD OF MERGING LIBRARIES OF MOLECULES USING VALIDATED MOLECULAR STRUCTURAL DESCRIPTORS AND NEIGHBORHOOD DISTANCES TO MAXIMIZE DIVERSITY AND MINIMIZE REDUNDANCY | February 2001 | September 2005 | Allow | 55 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ZEMAN, MARY K.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 30.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ZEMAN, MARY K works in Art Unit 1686 and has examined 94 patent applications in our dataset. With an allowance rate of 85.1%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 48 months.
Examiner ZEMAN, MARY K's allowance rate of 85.1% places them in the 56% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.
On average, applications examined by ZEMAN, MARY K receive 2.55 office actions before reaching final disposition. This places the examiner in the 86% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ZEMAN, MARY K is 48 months. This places the examiner in the 1% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +1.7% benefit to allowance rate for applications examined by ZEMAN, MARY K. This interview benefit is in the 18% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.
When applicants file an RCE with this examiner, 28.6% of applications are subsequently allowed. This success rate is in the 43% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 54.0% of cases where such amendments are filed. This entry rate is in the 76% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 50% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 86% percentile among all examiners. Of these withdrawals, 88.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 88.2% are granted (fully or in part). This grant rate is in the 94% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 7.4% of allowed cases (in the 93% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 7.5% of allowed cases (in the 84% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.